Project Number 5U01AG061173-03 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Optimization of microtubule-stabilizing triazolopyrimidines as therapeutics for Alzheimer's disease and related tauopathies Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator BRUNDEN, KURT R. Principal Investigator First Name KURT R. Principal Investigator Last Name BRUNDEN Awardee Organization UNIVERSITY OF PENNSYLVANIA Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-174: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $851,784 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YUAN, JEAN
